Search research articles
Contact Us
Filters
Showing results (311-320 of 420) with videos related to
Page
of 42
Sort By:
European Journal of Clinical Microbiology
|
August 1, 1987
Netilmicin disk susceptibility tests: effect of cations on the MIC correlates
A L Barry, G H Miller, R S Hare, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1983
In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits
P C Fuchs, A L Barry, C Thornsberry, et al.
Journal of Clinical Microbiology
|
May 1, 1982
In vitro evaluation of CENTA, a new beta-lactamase-susceptible chromogenic cephalosporin reagent
R N Jones, H W Wilson, W J Novick, et al.
Journal of Clinical Microbiology
|
May 1, 1982
Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits
R N Jones, T L Gavan, A L Barry, et al.
The Journal of Antibiotics
|
March 1, 1978
Stability of antimicrobials in Schaedler's anaerobic and brain heart infusion broths stored at --20 degrees C
R N Jones, R R Packer, P C Fuchs, et al.
Journal of Clinical Microbiology
|
September 1, 1987
In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination
R N Jones, A L Barry, R R Packer, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 1982
Sch 29482, a new oral penem: comparative in-vitro activity, beta-lactamase stability and inhibition
A L Barry, R N Jones, H W Wilson, et al.
Journal of Clinical Microbiology
|
March 1, 1984
Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa
A L Barry, G H Miller, R S Hare, et al.
Journal of Clinical Microbiology
|
June 1, 1983
Quality control of moxalactam susceptibility disks
A L Barry, D A Preston, R N Jones, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1981
Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testing
P C Fuchs, A L Barry, C Thornsberry, et al.
Page
of 42
Search research articles
Search
Showing results (311-320 of 420) with videos related to
Sort By:
Page
of 42
European Journal of Clinical Microbiology
|
August 1, 1987
Netilmicin disk susceptibility tests: effect of cations on the MIC correlates
A L Barry, G H Miller, R S Hare, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1983
In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits
P C Fuchs, A L Barry, C Thornsberry, et al.
Journal of Clinical Microbiology
|
May 1, 1982
In vitro evaluation of CENTA, a new beta-lactamase-susceptible chromogenic cephalosporin reagent
R N Jones, H W Wilson, W J Novick, et al.
Journal of Clinical Microbiology
|
May 1, 1982
Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits
R N Jones, T L Gavan, A L Barry, et al.
The Journal of Antibiotics
|
March 1, 1978
Stability of antimicrobials in Schaedler's anaerobic and brain heart infusion broths stored at --20 degrees C
R N Jones, R R Packer, P C Fuchs, et al.
Journal of Clinical Microbiology
|
September 1, 1987
In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination
R N Jones, A L Barry, R R Packer, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 1982
Sch 29482, a new oral penem: comparative in-vitro activity, beta-lactamase stability and inhibition
A L Barry, R N Jones, H W Wilson, et al.
Journal of Clinical Microbiology
|
March 1, 1984
Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa
A L Barry, G H Miller, R S Hare, et al.
Journal of Clinical Microbiology
|
June 1, 1983
Quality control of moxalactam susceptibility disks
A L Barry, D A Preston, R N Jones, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1981
Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testing
P C Fuchs, A L Barry, C Thornsberry, et al.
Page
of 42